Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOFACITINIB vs TOLODODEKIN ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOFACITINIB vs TOLODODEKIN ALFA: Safety Overview

Metric TOFACITINIB TOLODODEKIN ALFA
Total FAERS Reports 155,647 564
Deaths Reported 7,847 61
Death Rate 5.0% 10.8%
Hospitalizations 21,976 228
Average Patient Age 57.6 yrs 65.5 yrs
% Female Patients 81.6% 46.2%
FDA Approval Date Aug 19, 2021 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route ORAL N/A
Marketing Status Prescription N/A